GlassScriptPhysician profile
Boris Gershman
NPI 1013177518
$13,314.20
in general payments reported to CMS, 2019-2025
8 companies · $3,857 in 2025
The $3,857 reported for 2025 was more than what 89% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $69.17 · 2021: $1,200 · 2022: $872 · 2023: $1,016 · 2024: $6,300 · 2025: $3,857.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $7,076 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,800 · Food and Beverage: $297.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $7,075.95 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,800.00 |
| Food and Beverage | $296.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bk Medical Holding Company INC. | $7,316.09 | 2021-2024 | Bk3000, Bk3500 & Bk5000 Ultrasound System |
| Ferring Pharmaceuticals INC. | $2,984.24 | 2025 | Adstiladrin |
| Beckman Coulter, INC. | $2,000.00 | 2024 | Dxi 9000 Access Immunoassay Analyzer |
| Photocure INC | $822.18 | 2022-2025 | Cysview |
| Urogen Pharma, INC. | $122.52 | 2025 | |
| Pfizer INC. | $29.63 | 2019 | |
| Janssen Biotech, INC. | $25.14 | 2019 | |
| Blue Earth Diagnostics | $14.40 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Boris Gershman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.